Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Blueprint Medicines (United States)
InstitutionResearch output, impact & collaborations
Blueprint Medicines (United States) is a research organisation in Cambridge, US. OpenAlex records 826 works and 90,668 citations for it. 412 researchers list it as their most recent affiliation.
826
Works
90,668
Citations
412
Researchers
76.7
Avg h-index
How has Blueprint Medicines (United States)'s publication output changed over time?
ScholarIQpublication output · 2015–2020
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2020.
1
1
1
201520162020
What are the most-cited papers on Blueprint Medicines (United States)?
ScholarIQmost cited works
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Juliann Chmielecki, Xinyuan Lu, Todd M. Bauer, Mikhail Akimov, José A. Bufill, Carrie B. Lee, David Jentz, Rick Hoover, Sai‐Hong Ignatius Ou, Ravi Salgia, Timothy J. Brennan, Zachary R. Chalmers, Savina Jaeger, Alan Huang, Julia A. Elvin, Rachel Erlich, Alex Fichtenholtz, Kyle Gowen, Joel Greenbowe, Adrienne Johnson, Depinder Khaira, Caitlin McMahon, Eric M. Sanford, Steven Roels, Jared White, Joel Greshock, Robert Schlegel, Doron Lipson, Roman Yelensky, Deborah Morosini, Jeffrey S. Ross, Eric A. Collisson, Malte Peters, Philip J. Stephens, Vincent A. Miller
Cancer Discovery. 2015804 CitationsOPEN ACCESS
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon, Adam H. Buchanan, Isaac Kinde, Andrew Warren, Ashley Honushefsky, Ariella Cohain, David H. Ledbetter, Fred Sanfilippo, Kathleen Sheridan, Dillenia Rosica, Christian S. Adonizio, Hee Jung Hwang, Kamel Lahouel, Joshua D. Cohen, Christopher Douville, Aalpen A. Patel, Leonardo N. Hagmann, David D.K. Rolston, Nirav Malani, Shibin Zhou, Chetan Bettegowda, David L. Diehl, Bobbi Urban, Christopher D. Still, Lisa Kann, Julie Woods, Zachary Salvati, Joseph Vadakara, Rosemary Leeming, Prianka Bhattacharya, Carroll N. Walter, Alex Parker, Christoph Lengauer, Alison P. Klein, Cristian Tomasetti, Elliot K. Fishman, Ralph H. Hruban, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos
Science. 2020675 CitationsOPEN ACCESS
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
Alexa B. Schrock, Garrett M. Frampton, James Suh, Zachary R. Chalmers, Mark R. Rosenzweig, Rachel Erlich, Balázs Halmos, Jonathan W. Goldman, Patrick M. Forde, Kurt Leuenberger, Nir Peled, Gregory P. Kalemkerian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Sai‐Hong Ignatius Ou
Journal of Thoracic Oncology. 2016384 CitationsOPEN ACCESS
How much of the research on Blueprint Medicines (United States) is open access?
ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
33%
Bronze
33%
Closed
0%